Possible role of edotecarin, a novel topoisomerase I inhibitor, in therapy-related myelodysplastic syndrome. Article

Overview

authors

Carvajal, Richard D

Ilson, David
Noy, Ariela

publication date

January 1, 2007

published in

Leukemia & lymphoma Journal

Research

keywords

Antineoplastic Agents
Carbazoles
Indoles
Myelodysplastic Syndromes
Topoisomerase I Inhibitors

Identity

Scopus Document Identifier

34247255977

PubMed ID

17325867

Additional Document Info

volume

48

issue

1